Literature DB >> 15147339

Antiphospholipid syndrome: multiple mechanisms.

C G Mackworth-Young1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15147339      PMCID: PMC1809064          DOI: 10.1111/j.1365-2249.2004.02497.x

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


× No keyword cloud information.
  131 in total

1.  Hughes (antiphospholipid) syndrome. Clinical features.

Authors:  M J Cuadrado; G R Hughes
Journal:  Rheum Dis Clin North Am       Date:  2001-08       Impact factor: 2.670

Review 2.  How do antiphospholipid antibodies bind beta2-glycoprotein I?

Authors:  Ian P Giles; David A Isenberg; David S Latchman; Anisur Rahman
Journal:  Arthritis Rheum       Date:  2003-08

3.  Inhibition of the tissue factor-factor VII mediated activation of coagulation factor X by a monoclonal IgM antibody expressing lupus anticoagulant activity.

Authors:  O H Skjønsberg; F Wisløff; H C Godal
Journal:  Thromb Res       Date:  1990-05-01       Impact factor: 3.944

Review 4.  The biochemistry of haemostasis.

Authors:  S L Gonias; S V Pizzo
Journal:  Clin Lab Haematol       Date:  1986

5.  Impaired catalytic function of activated protein C: a new in vitro manifestation of lupus anticoagulant.

Authors:  E Marciniak; E H Romond
Journal:  Blood       Date:  1989-11-15       Impact factor: 22.113

6.  Activated protein C stimulates the fibrinolytic activity of cultured endothelial cells and decreases antiactivator activity.

Authors:  Y Sakata; S Curriden; D Lawrence; J H Griffin; D J Loskutoff
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

Review 7.  Antiphospholipid antibodies in an in vivo thrombosis model in mice.

Authors:  S S Pierangeli; E N Harris
Journal:  Lupus       Date:  1994-08       Impact factor: 2.911

8.  Lupus anticoagulant: an analysis of the clinical and laboratory features of 219 cases.

Authors:  D A Gastineau; F J Kazmier; W L Nichols; E J Bowie
Journal:  Am J Hematol       Date:  1985-07       Impact factor: 10.047

9.  Relationship between anti-cardiolipin and anti-endothelial cell antibodies in systemic lupus erythematosus.

Authors:  A Vismara; P L Meroni; A Tincani; E N Harris; W Barcellini; A Brucato; M Khamashta; G R Hughes; C Zanussi; G Balestrieri
Journal:  Clin Exp Immunol       Date:  1988-11       Impact factor: 4.330

10.  Risk factors for coronary artery disease in patients with systemic lupus erythematosus.

Authors:  M Petri; S Perez-Gutthann; D Spence; M C Hochberg
Journal:  Am J Med       Date:  1992-11       Impact factor: 4.965

View more
  25 in total

Review 1.  Antiphospholipid antibodies in young adults with stroke.

Authors:  Robin L Brey
Journal:  J Thromb Thrombolysis       Date:  2005-10       Impact factor: 2.300

2.  Dyslipidemia and its relationship with antiphospholipid antibodies in APS patients in North Kerala.

Authors:  Shajit Sadanand; Binoy J Paul; Emil J Thachil; Rejadheesh Meletath
Journal:  Eur J Rheumatol       Date:  2016-12-01

Review 3.  Is there a microangiopathic antiphospholipid syndrome?

Authors:  Ronald A Asherson; Sylvia S Pierangeli; Ricard Cervera
Journal:  Ann Rheum Dis       Date:  2007-04       Impact factor: 19.103

4.  Antiphospholipid Syndrome during pregnancy: the state of the art.

Authors:  Fosca A F Di Prima; Oriana Valenti; Entela Hyseni; Elsa Giorgio; Marianna Faraci; Eliana Renda; Roberta De Domenico; Santo Monte
Journal:  J Prenat Med       Date:  2011-04

Review 5.  Neurological and Neurosurgical Emergencies in Patients with Hematological Disorders.

Authors:  Martha L Cruz; Shama Farooq; Fernando D Testai
Journal:  Curr Neurol Neurosci Rep       Date:  2017-03       Impact factor: 5.081

6.  Clinical characteristics and thrombosis outcomes of paediatric antiphospholipid syndrome: analysis of 58 patients.

Authors:  Jingran Ma; Hongmei Song; Min Wei; Yanyan He
Journal:  Clin Rheumatol       Date:  2017-07-26       Impact factor: 2.980

Review 7.  [Antiphospholipid syndrome 2007. Current aspects of laboratory diagnostics and their therapeutic consequences].

Authors:  S Schuchmann; T Dörner
Journal:  Z Rheumatol       Date:  2007-05       Impact factor: 1.372

8.  Possible Effect of Extended Use of Hormonal Contraception on Increased Levels of Antiphospholipid Antibodies in Infertile Women.

Authors:  Z Ulcova-Gallova; K Bibkova; Z Micanova; P Losan; K Babcova
Journal:  Geburtshilfe Frauenheilkd       Date:  2015-03       Impact factor: 2.915

9.  Serum complement activation on heterologous platelets is associated with arterial thrombosis in patients with systemic lupus erythematosus and antiphospholipid antibodies.

Authors:  E I B Peerschke; W Yin; D R Alpert; R A S Roubey; J E Salmon; B Ghebrehiwet
Journal:  Lupus       Date:  2009-05       Impact factor: 2.911

10.  Some antiphospholipid antibodies recognize conformational epitopes shared by beta2-glycoprotein I and the homologous catalytic domains of several serine proteases.

Authors:  Wei-Shiang Lin; Pei-Chih Chen; Cheng-De Yang; EunJung Cho; Bevra H Hahn; Jennifer Grossman; Kwan-Ki Hwang; Pojen P Chen
Journal:  Arthritis Rheum       Date:  2007-05
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.